1. Scrip
  2. >>Therapy Areas

Teva's AirDuo Authorized Generic Priced At A 70% Discount To Advair

 
• By Jessica Merrill

Teva's decision to launch an authorized generic version of AirDuo, a drug made up of the same active ingredients in GSK's Advair, at a steep discount to typical brand drugs for asthma will help encourage use, even though it is not interchangeable.

AirDuo RespiClick inhalers

Teva Pharmaceutical Industries Ltd. has taken the interesting step of launching AirDuo RespiClick (fluticasone/salmeterol) and an aggressively discounted authorized generic in the US on the same day. The company announced the availability of the two products April 20, both of which are formulated with the same active ingredients as GlaxoSmithKline PLC's AdvairDiskus, but are administered through a different device.

The authorized generic is priced at a steep discount to the AirDuo brand product – and to the leading brands...

More from Respiratory

More from Therapy Areas

Sanofi Revels In More Positive Rilzabrutinib Data

 
• By Kevin Grogan

The oral BTK inhibitor impresses in a Phase II trial for IgG4-related disease.

BioNTech To Buy mRNA Rivals CureVac

 
• By Andrew McConaghie

The $1.25bn buyout is a simple deal for BioNTech, bringing new mRNA R&D and manufacturing capacity while also ending a bothersome patent dispute.

Is Zydus’s Agenus Deal Opportunistic Or Strategic?

 
• By Vibha Ravi

Will Zydus’s acquisition and licensing deal with Agenus turn out to be a strategic move towards building an oncology portfolio or an opportunistic one driven by a venture capital mindset?